Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

A van der Veer; V H J van der Velden; M E Willemse; P G Hoogeveen; E F Petricoin; H B Beverloo; G Escherich; M A Horstmann; R Pieters; M L den Boer

doi:10.1038/bcj.2014.5

Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

A van der Veer, V H J van der Velden, M E Willemse, P G Hoogeveen, E F Petricoin, H B Beverloo, G Escherich, M A Horstmann, R Pieters, M L den Boer

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

19 Citaten (Scopus)

Originele taal-2	Engels
Artikelnummer	20145
Pagina's (van-tot)	e181
Tijdschrift	Blood cancer journal
Volume	4
Nummer van het tijdschrift	2
DOI's	https://doi.org/10.1038/bcj.2014.5
Status	Gepubliceerd - 14 feb. 2014
Extern gepubliceerd	Ja

Toegang tot document

10.1038/bcj.2014.5

Citeer dit

van der Veer, A., van der Velden, V. H. J., Willemse, M. E., Hoogeveen, P. G., Petricoin, E. F., Beverloo, H. B., Escherich, G., Horstmann, M. A., Pieters, R., & den Boer, M. L. (2014). Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia. Blood cancer journal, 4(2), e181. Artikel 20145. https://doi.org/10.1038/bcj.2014.5

@article{2058d6d97b7f4a268c86c7dd4227e836,

title = "Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia",

author = "{van der Veer}, A and {van der Velden}, {V H J} and Willemse, {M E} and Hoogeveen, {P G} and Petricoin, {E F} and Beverloo, {H B} and G Escherich and Horstmann, {M A} and R Pieters and {den Boer}, {M L}",

note = "Funding Information: This work was supported by the Dutch Cancer Society (KWF, grant EMCR 2007-3718 to MLDB and RP, grant EMCR 2006-3547 to VHJVDV), the Sophia Foundation for Scientific Research (SSWO, grant 658; AVDV, MLDB) and the Pediatric Oncology Foundation Rotterdam (MLDB, RP). These funding sources had no role in the collection, analysis or interpretation of the results, or in writing the manuscript and the decision for submission of this manuscript.",

year = "2014",

month = feb,

day = "14",

doi = "10.1038/bcj.2014.5",

language = "English",

volume = "4",

pages = "e181",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Springer Nature",

number = "2",

}

van der Veer, A, van der Velden, VHJ, Willemse, ME, Hoogeveen, PG, Petricoin, EF, Beverloo, HB, Escherich, G, Horstmann, MA, Pieters, R & den Boer, ML 2014, 'Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia', Blood cancer journal, vol. 4, nr. 2, 20145, blz. e181. https://doi.org/10.1038/bcj.2014.5

TY - JOUR

T1 - Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

AU - van der Veer, A

AU - van der Velden, V H J

AU - Willemse, M E

AU - Hoogeveen, P G

AU - Petricoin, E F

AU - Beverloo, H B

AU - Escherich, G

AU - Horstmann, M A

AU - Pieters, R

AU - den Boer, M L

N1 - Funding Information: This work was supported by the Dutch Cancer Society (KWF, grant EMCR 2007-3718 to MLDB and RP, grant EMCR 2006-3547 to VHJVDV), the Sophia Foundation for Scientific Research (SSWO, grant 658; AVDV, MLDB) and the Pediatric Oncology Foundation Rotterdam (MLDB, RP). These funding sources had no role in the collection, analysis or interpretation of the results, or in writing the manuscript and the decision for submission of this manuscript.

PY - 2014/2/14

Y1 - 2014/2/14

UR - http://www.scopus.com/inward/record.url?scp=84895452149&partnerID=8YFLogxK

U2 - 10.1038/bcj.2014.5

DO - 10.1038/bcj.2014.5

M3 - Article

C2 - 24531445

SN - 2044-5385

VL - 4

SP - e181

JO - Blood cancer journal

JF - Blood cancer journal

IS - 2

M1 - 20145

ER -